Provided by Tiger Fintech (Singapore) Pte. Ltd.

TriSalus Life Sciences Inc.

5.19
-0.3100-5.64%
Post-market: 5.190.00000.00%16:04 EDT
Volume:34.60K
Turnover:184.10K
Market Cap:196.38M
PE:-4.56
High:5.53
Open:5.34
Low:5.08
Close:5.50
Loading ...
Apr 11, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 11, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 01, 2024

Major Issues Report

Form 8-K - Current report
Mar 12, 2024

Major Issues Report

Form 8-K - Current report
Jan 25, 2024

Major Issues Report

Form 8-K - Current report
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Dec 21, 2023

Correspondence

Form CORRESP - Correspondence
Dec 21, 2023

Correspondence

Form CORRESP - Correspondence
Dec 15, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 15, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dec 14, 2023

Correspondence

Form CORRESP - Correspondence
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2023

Major Issues Report

Form 8-K - Current report
Oct 19, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Oct 18, 2023

Correspondence

Form CORRESP - Correspondence
Oct 16, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Oct 03, 2023

Major Issues Report

Form 8-K - Current report
Sep 02, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Sep 01, 2023

Major Issues Report

Form 8-K - Current report
Aug 31, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933